This week’s Bulls N’ Bears ASX Runners of the Week is… Lumos Diagnostics. New record highs on the ASX? Yawn. Market speculators are at it again, betting big on an “inevitable” August interest rate cut after Australian employment figures came in softer than a summer breeze. The Reserve Bank is being cautious and still wants to eyeball the quarterly inflation data before it jumps. But the market’s already off to the races, soaring more than two per cent from Thursday morning li

This week’s Bulls N’ Bears ASX Runner of the Week is… Osteopore Limited. Credit: Bulls N' Bears/File Hold on to your hats, ladies and gentlemen, it’s been less of a rollercoaster ride than it was a ferocious bucking bull on the markets this week. The market opened the week with near-record losses after China retaliated with tariffs in the United States, which saw the S&P 500 shed more than $5.8 trillion in value in four days. It was the largest value drop in the index’s histo

Sit back. Take a deep breath and just relax, your share portfolio is doing just fine. Or at least it is if you have stock in The Calmer Co International (ASX: CCO). With a massive jump of more than 185 per cent, the company is this week’s Bulls N’ Bears ASX Runner of the Week after surging from 0.7c to touch 2c. The Calmer Co’s mission to provide natural solutions to calm the nerves, induce sleep and support mind and muscle relaxation, appears to be a hit with customers after

Creaky knees are the scourge of those people in society who are nearer to their twilight than they are to their time as a toddler. And that may go some way towards explaining why a company trying to fix the dodgy leg joints saw its share price shoot sky-high on the ASX this week. It is impossible to ascertain, but maybe it was a pack of mature shareholders who braved their knee pain and hobbled to their laptops and jumped into Osteopore’s stock, kicking it up more than a stun

With this year’s Olympic Games in Paris drawing closer, the temptation to draw comparisons between high-performing ASX stocks and high-performance athletes becomes more and more enticing. If ASX-listed Osteopore (ASX: OSX) was an Olympic athlete, it would have been gold, gold, gold this week for the regenerative bone implant technologist who achieved the impossible Olympic sized dream of a “ten-bagger” share price hike. The company’s stock hiked 1060 per cent from 6.5c last w